AZD0530, AN INHIBITOR OF SRC KINASES, IN PLATINUM-PRETREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A TRIAL OF THE PMH PHASE II CONSORTIUM

被引：0
|
作者：
Laurie, Scott A. [1 ]
Goss, Glenwood D. [1 ]
Shepherd, Frances A. [2 ]
Reaume, Neil [1 ]
Nicholas, Garth [1 ]
Philip, Lindsay [2 ]
Wang, Lisa [2 ]
Oza, Amit [2 ]
Hirsh, Vera [3 ]
Wright, James
Leighl, Natasha [2 ]
机构：
[1] Ottawa Hosp Canc Ctr, Ottawa, ON, Canada
[2] Princess Margaret Hosp, Toronto, ON, Canada
[3] Mcgill Univ Hlth Ctr, Dept Oncol, Montreal, PQ, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
src kinase inhibitor; non-small cell; Phase II;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1262 / S1262
页数：1
相关论文
共 50 条
  • [21] A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC)
    Sovak, M. A.
    Lutzker, S.
    Guensch, L.
    Joyce, M.
    Schwartz, S.
    Wu, Y.
    Zheng, L.
    Aisner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study
    Ailsa J. Oswald
    Stefan N. Symeonides
    Duncan Wheatley
    Stephen Chan
    Adrian Murray Brunt
    Karen McAdam
    Peter Schmid
    Simon Waters
    Christopher Poole
    Chris Twelves
    Timothy Perren
    John Bartlett
    Tammy Piper
    Eve Macdonald Chisholm
    Michelle Welsh
    Robert Hill
    Lisa E. M. Hopcroft
    Peter Barrett-Lee
    David A. Cameron
    Breast Cancer Research and Treatment, 2023, 199 : 35 - 46
  • [23] Phase II study of celecoxib and weekly paclitaxel in the treatment of pretreated advanced non-small cell lung cancer (NSCLC).
    Stani, SC
    Carillio, G
    Meo, S
    Morabito, A
    Bonginelli, P
    Comella, G
    Mansueto, G
    Avallone, A
    Gion, M
    Gasparini, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 700S - 700S
  • [24] Phase II Trial of Saracatinib (AZD0530), an Oral SRC-inhibitor for the Treatment of Patients with Hormone Receptor-negative Metastatic Breast Cancer
    Gucalp, Ayca
    Sparano, Joseph A.
    Caravelli, James
    Santamauro, Jean
    Patil, Sujata
    Abbruzzi, Alyson
    Pellegrino, Christine
    Bromberg, Jackie
    Dang, Chau
    Theodoulou, Maria
    Massague, Joan
    Norton, Larry
    Hudis, Clifford
    Traina, Tiffany A.
    CLINICAL BREAST CANCER, 2011, 11 (05) : 306 - 311
  • [25] Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)
    Antón, A
    Díaz-Fernández, N
    Larriba, JG
    Vadell, C
    Masutti, B
    Montalar, J
    Barneto, I
    Artal, A
    Rosell, R
    LUNG CANCER, 1998, 22 (02) : 139 - 148
  • [26] Metformin as a repurposed therapy in advanced non-small cell lung cancer (NSCLC): results of a phase II trial
    Anish B. Parikh
    Peter Kozuch
    Nicholas Rohs
    Daniel J. Becker
    Benjamin P. Levy
    Investigational New Drugs, 2017, 35 : 813 - 819
  • [27] Metformin as a repurposed therapy in advanced non-small cell lung cancer (NSCLC): results of a phase II trial
    Parikh, Anish B.
    Kozuch, Peter
    Rohs, Nicholas
    Becker, Daniel J.
    Levy, Benjamin P.
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (06) : 813 - 819
  • [28] PHASE-II TRIAL OF ORAL IDARUBICIN IN ADVANCED NON-SMALL CELL LUNG-CANCER (NSCLC)
    ARDIZZONI, A
    PRONZATO, P
    REPETTO, L
    DEPALMA, M
    CANOBBIO, L
    GULISANO, M
    FUSCO, V
    ROSSO, R
    GANZINA, F
    CANCER INVESTIGATION, 1988, 6 (04) : 409 - 411
  • [29] A phase II clinical and PET study of erlotinib and bexarotene for heavily pretreated advanced non-small cell lung cancer (NSCLC)
    Dragnev, K. H.
    Rigas, J. R.
    Seltzer, M.
    DiSalvo, W.
    Simeone, S.
    Johnstone, D.
    Nugent, W.
    Dmitrovsky, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] Phase I/II study of biweekly nab-paclitaxel in patients with platinum-pretreated non-small cell lung cancer: NJLCG1402
    Miyauchi, Eisaku
    Tanaka, Hisashi
    Nakamura, Atsushi
    Harada, Toshiyuki
    Nakagawa, Taku
    Morita, Mami
    Jingu, Daisuke
    Kuda, Tomoya
    Gamou, Shunichi
    Saito, Ryota
    Inoue, Akira
    THORACIC CANCER, 2021, 12 (21) : 2886 - 2893
12345